Home
About BEB
Curriculum
Admission
CNC Research
BEB in the Media
 
 
MIT-PT PROGRAMME 2008/2009
 
February 2 - 13
ELECTIVE COURSE

PRINCIPLES AND PRACTICE IN DRUG DEVELOPMENT

Center for Neuroscience and Cell Biology, University of Coimbra

João Nuno Moreira, Luís Almeida, Sérgio Simões, Conceição Pedroso de Lima, Stan Finkelstein
·    February 2
9 h – Introduction to the course
Conceição Pedroso de Lima, Ph. D. (CNC)
Sérgio Simões, Ph. D. (CNC)
João Nuno Moreira, Ph. D. (CNC)
Luís Pereira de Almeida, Ph. D. (CNC)
 
10 h - The Pharmaceutical Industry and the Drug Development Process
Stan N. Finkelstein, M.D., Ph. D. (Senior Research Assistant in the MIT Engineering Systems Division and the Harvard-MIT Division of Health Sciences and Technology)
 
 
16 h - Basic Science I – Discovery Innovation and Emerging Technologies; Basic Business
Anthony J. Sinskey, Ph.D. (Professor of Biology at MIT)
 
·    February 3
10 h – Drugable biological targets and concept design
Patrício Soares da Silva, Ph. D. (BIAL, Indústria Farmacêutica, Portugal)
 
11 h – Development of new chemical entities: from bench to industrial production
David A. Learmonth, Ph. D. (BIAL, Indústria Farmacêutica, Portugal)
 
12 h - Pharmacology and toxicology of new chemical entities
Lyndon C. Wright, Ph. D. (BIAL, Indústria Farmacêutica, Portugal)
 
14 h – Clinical development of CNS active drugs
Luis Almeida, Ph. D. (BIAL, Indústria Farmacêutica, Portugal)
 
16 h - Basic Science II – Molecular Toxicology in Preclinical Studies
Anthony J. Sinskey, Ph.D. (Professor of Biology at MIT)
 
·    February 4
10 h – Targeted therapies: the promise of the biopharmaceuticals
António Freitas Duarte, Ph. D. (CEO GenIBET Biopharmaceuticals, Faculty of Veterinary Medicine, UTL, Instituto Gulbenkian de Ciência)
11 h - Some issues in drug development: discussion of case studies
Miguel Prazeres, Ph. D. (Instituto Superior Técnico, Technical University of Lisbon)
 
 
14.30 h – Discussion Forum
 
16 h – Drug development and clinical trials
Howard Golub, Ph. D. (Senior Lecturer, Harvard-MIT Division of Health Sciences and Technology)
 
·    February 5
9 h - FDA Process, Off-Label Prescribing, Insurance Coverage
Stan N. Finkelstein, M.D., Ph. D. (Senior Research Assistant in the MIT Engineering Systems Division and the Harvard-MIT Division of Health Sciences and Technology)
 
16 h – Technology transfer – the perspective from MIT
Lauren Foster (MIT, USA)
·    February 6
10 h – Regulatory Affairs – the perspective from EMEA
Rogério Gaspar, Ph. D. (Faculty of Pharmacy, University of Lisbon, Portugal)
 
14 h – Visit to Bluepharma, Pharmaceutical Industry SA
 
 
·    February 9
10 h – Alfama – the entrepreneurial side of drug development
Nuno Arantes-Oliveira, Ph. D. (President and CEO of Alfama)
 
14.30 h – Discussion Forum
 
16 h - Biotech Cluster Study and Related Issues
Thomas J. Allen, Ph.D. (Howard Johnson Professor Emeritus of Management at MIT)
·    February 10
9 h – Nanotechnology for drug and gene targeting
Conceição Pedroso de Lima, Ph. D. (CNC, Portugal)
Sérgio Simões, Ph. D. (CNC, Portugal)
João Nuno Moreira, Ph. D. (CNC, Portugal)
Luís Pereira Almeida, Ph. D. (CNC, Portugal)
 
10 h - Nanotechnology for drug and gene targeting(cont.)
 
 
14.30 h – Visit to Biocant Park – Innovation Center in Biotechnology
 
·    February 11
9 h – Drug distribution in developing countries
Prashant Yadav, Ph. D. (professor at the Zaragoza Logistics Center in Spain)
 
 
16 h - Economic evaluation of pharmaceuticals
Terrence Norchi, Ph. D. (CEO of Arch Therapeutics)
 
·    February 12
9 h – Manufacturing I
Charles L. Cooney, Ph. D. (Robert T. Haslam Professor of Chemical Engineering at MIT)
 
16 h – Manufacturing II
Charles L. Cooney, Ph. D. (Robert T. Haslam Professor of Chemical Engineering at MIT)
 
·    February 13
Students’ pr
back
 
© 2017 BEB - Doctoral Programme in Experimental Biology and Biomedicine powered by ponto.C